VARICELLA-ZOSTER VIRUS
Clinical trials for VARICELLA-ZOSTER VIRUS explained in plain language.
Never miss a new study
Get alerted when new VARICELLA-ZOSTER VIRUS trials appear
Sign up with your email to follow new studies for VARICELLA-ZOSTER VIRUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New mRNA shingles vaccine enters human testing
⭐️ VACCINE ⭐️ OngoingThis early-stage trial tests a new mRNA vaccine (ABO1108) for shingles in 180 healthy adults aged 40 and older. Participants receive two shots about two months apart at different dose levels. The study focuses on safety and how well the vaccine triggers an immune response.
Matched conditions: VARICELLA-ZOSTER VIRUS
Phase: PHASE1 • Sponsor: Suzhou Abogen Biosciences Co., Ltd. • Aim: ⭐️ VACCINE ⭐️
Last updated May 17, 2026 19:34 UTC
-
New mRNA shingles vaccine shows promise in Mid-Stage trial
⭐️ VACCINE ⭐️ OngoingThis study tests a new mRNA vaccine (ABO1108) to see if it can safely prevent shingles in adults aged 40 and above. Around 300 healthy participants will receive two shots, two months apart, and be compared to a placebo group. The goal is to measure the body's immune response and …
Matched conditions: VARICELLA-ZOSTER VIRUS
Phase: PHASE2 • Sponsor: Suzhou Abogen Biosciences Co., Ltd. • Aim: ⭐️ VACCINE ⭐️
Last updated May 12, 2026 13:40 UTC